Table of Contents Author Guidelines Submit a Manuscript
Prostate Cancer
Volume 2015, Article ID 624736, 11 pages
Review Article

Systematic Review of the Relationship between Acute and Late Gastrointestinal Toxicity after Radiotherapy for Prostate Cancer

1Department of Radiation Oncology, University of Virginia School of Medicine, Charlottesville, VA 22908, USA
2Department of Radiation Oncology, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY 10467, USA

Received 1 October 2015; Accepted 15 November 2015

Academic Editor: Robert Gardiner

Copyright © 2015 Matthew Sean Peach et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [11 citations]

The following is the list of published articles that have cited the current article.

  • Rupak Pathak, Junru Wang, Sarita Garg, Nukhet Aykin-Burns, Karl-Uwe Petersen, and Martin Hauer-Jensen, “Recombinant Thrombomodulin (Solulin) Ameliorates Early Intestinal Radiation Toxicity in a Preclinical Rat Model,” Radiation Research, vol. 186, no. 2, pp. 112–120, 2016. View at Publisher · View at Google Scholar
  • M. Bonet, L. Cayetano, M. Núñez, E. Jovell-Fernández, A. Aguilar, and Y. Ribas, “Assessment of acute bowel function after radiotherapy for prostate cancer: Is it accurate enough?,” Clinical and Translational Oncology, 2017. View at Publisher · View at Google Scholar
  • Guojun Hou, Huilin Que, Jie Sun, and Tiefeng Jin, “Inhibitory effect of BEZ235 on human prostate carcinoma in vitro,” Journal of Central South University (Medical Sciences), vol. 42, no. 8, pp. 869–873, 2017. View at Publisher · View at Google Scholar
  • Na-Kyung Han, Ye Ji Jeong, Bo-Jeong Pyun, Yoon-Jin Lee, Sung-Ho Kim, and Hae-June Lee, “Geranylgeranylacetone Ameliorates Intestinal Radiation Toxicity by Preventing Endothelial Cell Dysfunction,” International Journal of Molecular Sciences, vol. 18, no. 10, pp. 2103, 2017. View at Publisher · View at Google Scholar
  • Varga Linda, Bajory Zoltán, Pajor László, Révész János, Sükösd Farkas, and Maráz Anikó, “Edifications and modern strategies of localized prostate cancers' definitive therapy,” Orvosi Hetilap, vol. 159, no. 32, pp. 1317–1325, 2018. View at Publisher · View at Google Scholar
  • Hanne Tøndel, Jo Åsmund Lund, and Arne Solberg, “Response to Alongi et al.,” Radiotherapy and Oncology, 2018. View at Publisher · View at Google Scholar
  • Mitchell S. Anscher, Michael G. Chang, Drew Moghanaki, Mihaela Rosu, Ross B. Mikkelsen, Diane Holdford, Vicki Skinner, Baruch M. Grob, Arun Sanyal, Aiping Wang, and Nitai D. Mukhopadhyay, “A Phase II Study to Prevent Radiation-induced Rectal Injury With Lovastatin,” American Journal of Clinical Oncology, vol. 41, no. 6, pp. 544–548, 2018. View at Publisher · View at Google Scholar
  • A. Lemanska, D.P. Dearnaley, R. Jena, M.R. Sydes, and S. Faithfull, “Older Age, Early Symptoms and Physical Function are Associated with the Severity of Late Symptom Clusters for Men Undergoing Radiotherapy for Prostate Cancer,” Clinical Oncology, 2018. View at Publisher · View at Google Scholar
  • Douglas H Brand, Alison C Tree, Peter Ostler, Hans van der Voet, Andrew Loblaw, William Chu, Daniel Ford, Shaun Tolan, Suneil Jain, Alexander Martin, John Staffurth, Philip Camilleri, Kiran Kancherla, John Frew, Andrew Chan, Ian S Dayes, Daniel Henderson, Stephanie Brown, Clare Cruickshank, Stephanie Burnett, Aileen Duffton, Clare Griffin, Victoria Hinder, Kirsty Morrison, Olivia Naismith, Emma Hall, Nicholas van As, D Dodds, E Lartigau, S Patton, A Thompson, M Winkler, P Wells, T Lymberiou, D Saunders, M Vilarino-Varela, P Vavassis, T Tsakiridis, R Carlson, G Rodrigues, J Tanguay, S Iqbal, M Winkler, S Morgan, A Mihai, A Li, O Din, M Panades, R Wade, Y Rimmer, J Armstrong, M Panades, and N Oommen, “Intensity-modulated fractionated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): acute toxicity findings from an international, randomised, open-label, phase 3, non-inferiority trial,” The Lancet Oncology, 2019. View at Publisher · View at Google Scholar
  • Annique C. Dombrowsky, Jannis Schauer, Matthias Sammer, Andreas Blutke, Dietrich W. M. Walsh, Benjamin Schwarz, Stefan Bartzsch, Annette Feuchtinger, Judith Reindl, Stephanie E. Combs, Günther Dollinger, and Thomas E. Schmid, “Acute Skin Damage and Late Radiation-Induced Fibrosis and Inflammation in Murine Ears after High-Dose Irradiation,” Cancers, vol. 11, no. 5, pp. 727, 2019. View at Publisher · View at Google Scholar
  • Ghanyah Al-Qadami, Ysabella Van Sebille, Hien Le, and Joanne Bowen, “Gut microbiota: implications for radiotherapy response and radiotherapy-induced mucositis,” Expert Review of Gastroenterology & Hepatology, pp. 1–12, 2019. View at Publisher · View at Google Scholar